Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

New compounds were made that are promising for prostate cancer therapy.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Eflornithine improved symptoms in Bachmann–Bupp Syndrome patients.

Certain Dibenzo derivatives may help treat prostate cancer.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

A new treatment for hair loss shows promise with fewer side effects.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Dendrobium officinale polysaccharide helps hair growth by activating the WNT signaling pathway.

New drugs like clonidine and prazosin show promise for treating high blood pressure despite some side effects.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Choose treatments for sex offenders based on individual needs, using hormonal and nonhormonal options to reduce sexual drive.

TA-Ado effectively promotes hair growth and reduces hair loss.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Haloperidol decanoate can cause alopecia areata.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.